Mice heterozygous for an adenomatosis polyposis coli (APC) mutation and an LRH-1 inactivating mutation developed fewer intestinal tumours than mice harbouring the APC mutation only, and LRH-1 heterozygous mice developed fewer azoxymethane-induced aberrant crypt foci (46). Here, NR5A2 is linked to intestinal neoplasm.